Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

DalCor Pharmaceuticals

DalCor Pharmaceuticals?uq=3Oe4kK1Z
2015 FOUNDED
PRIVATE STATUS
Series B LATEST DEAL TYPE
$99M LATEST DEAL AMOUNT
5 INVESTORS
Description

Developer of precision medicine intended to cure cardiovascular diseases. The company's products integrate clinical, biologic and genetic insights to reduce cardiovascular events in a genetically distinct subset of patients by genetically targeting patients.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • 1010 Sherbrooke Street West
  • Suite 408
  • Montreal, Quebec H3A 2R7
  • Canada

+1 (514) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore DalCor Pharmaceuticals’s full profile, request a free trial.

DalCor Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 13-May-2016 $99M 00000 Completed Clinical Trials - Phase 3
1. Early Stage VC (Series A) 01-Jan-2015 0000 0000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

DalCor Pharmaceuticals Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Caisse de dépôt et placement du Québec PE/Buyout Minority 000 0000 000000 0
CTI Life Sciences Fund Venture Capital Minority 000 0000 000000 0
Fonds de solidarité FTQ Venture Capital Minority 000 0000 000000 0
Andre Desmarais Angel (individual) Minority 000 0000 000000 0
Sanderling Ventures Venture Capital Minority 000 0000 000000 0

DalCor Pharmaceuticals Executive Team (4)

Name Title Board
Seat
Contact
Info
Donald Black MD Chief Medical Officer
Robert McNeil Ph.D Chief Executive Officer & Chairman
Michael Dixon Chief Financial Officer
Louise Proulx Ph.D Chief Development Officer

DalCor Pharmaceuticals Board Members (6)

Name Representing Role Since Contact
Info
Domitille de Vienne DalCor Pharmaceuticals Board Member 000 0000
Henry d'Abo DalCor Pharmaceuticals Board Member 000 0000
Jane Hubbard - Guyett DalCor Pharmaceuticals Board Member 000 0000
Robert McNeil Ph.D Self Chief Executive Officer & Chairman 000 0000
Rody Yared Trussbridge Director 000 0000
You’re viewing 5 of 6 board members. Get the full list »